Published Online First

Pharmacogenomics of Anti-TNF Treatment Response Marks a New Era of Tailored Rheumatoid Arthritis Therapy

Tomasz Wysocki
Agnieszka Paradowska-Gorycka

February 2022

Rheumatoid arthritis (RA) is the most commonly occurring chronic inflammatory arthritis, the exact m...

Lack of Association of Variants Previously Associated with Anti-TNF Medication Response in Rheumatoid Arthritis Patients: Results from a Homogeneous Greek Population

Maria I. Zervou
Efsevia Myrthianou
Irene Flouri
Darren Plant
Gregory Chlouverakis
Panayiota Rapsomaniki
Anne Barton
Dimitrios T. Boumpas
George N. Goulielmos

August 2016

Treatment strategies blocking tumor necrosis factor (anti-TNF) have proven very successful in patien...

Published Online First

P P Tak
Slotervaart Hospital
Rheumatology F

January 2007

The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tum...

Ann Rheum Dis. Author manuscript

Miceli-richard Corinne
Comets Emmanuelle
Verstuyft C
Tamouza Ryad
Loiseau Pascale
Becquemont Laurent
Charron Dominique
Mariette Xavier

December 2014

A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthri...

Ann Rheum Dis. Author manuscript

Miceli-richard Corinne
Comets Emmanuelle
Verstuyft C
Tamouza Ryad
Loiseau Pascale
Becquemont Laurent
Charron Dominique
Mariette Xavier

September 2016

A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthri...

4

Verstuyft C
Tamouza R
Loiseau P
Ravaud P
Becquemont L
Charron D
Mariette X

June 2015

1 A single tumor necrosis factor α haplotype influences response to adalimumab in rheumatoid arthrit...

A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis.

Miceli-Richard, Corinne
Comets, Emmanuelle
Verstuyft, C.
Tamouza, Ryad
Loiseau, Pascale
Ravaud, Philippe
Kupper, H.
Becquemont, Laurent
Charron, Dominique
Mariette, Xavier

April 2008

International audienceOBJECTIVE: To determine whether tumour necrosis factor (TNF) gene polymorphism...

A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis.

Miceli-Richard, Corinne
Comets, Emmanuelle
Verstuyft, C.
Tamouza, Ryad
Loiseau, Pascale
Ravaud, Philippe
Kupper, H.
Becquemont, Laurent
Charron, Dominique
Mariette, Xavier

April 2008

International audienceOBJECTIVE: To determine whether tumour necrosis factor (TNF) gene polymorphism...

A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis.

Miceli-Richard, Corinne
Comets, Emmanuelle
Verstuyft, C.
Tamouza, Ryad
Loiseau, Pascale
Ravaud, Philippe
Kupper, H.
Becquemont, Laurent
Charron, Dominique
Mariette, Xavier

April 2008

International audienceOBJECTIVE: To determine whether tumour necrosis factor (TNF) gene polymorphism...

A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis.

Miceli-Richard, Corinne
Comets, Emmanuelle
Verstuyft, C.
Tamouza, Ryad
Loiseau, Pascale
Ravaud, Philippe
Kupper, H.
Becquemont, Laurent
Charron, Dominique
Mariette, Xavier

April 2008

International audienceOBJECTIVE: To determine whether tumour necrosis factor (TNF) gene polymorphism...

The tumour necrosis factor receptor superfamily member 1b 676T>G polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritis.

Toonen, E.J.M.
Coenen, M.J.H.
Kievit, W.
Fransen, J.
Eijsbouts, A.M.M.
Scheffer, H.
Radstake, T.R.D.J.
Creemers, M.C.W.
Rooij, D.J. de
Riel, P.L.C.M. van
Franke, B.
Barrera, P.

January 2008

OBJECTIVE: To assess the effect of a functional polymorphism (676T>G, M196R) in the tumour necrosis ...

The tumour necrosis factor receptor superfamily member 1b 676T>G polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritis.

Toonen, E.J.M.
Coenen, M.J.H.
Kievit, W.
Fransen, J.
Eijsbouts, A.M.M.
Scheffer, H.
Radstake, T.R.D.J.
Creemers, M.C.W.
Rooij, D.J. de
Riel, P.L.C.M. van
Franke, B.
Barrera, P.

January 2008

Item does not contain fulltextOBJECTIVE: To assess the effect of a functional polymorphism (676T>G, ...

The influence of TNFA genetic polymorphisms in the response to immunomodulatory drugs in patients with rheumatoid arthritis: a systematic review

Clemente, Daniela
Santos, Marlene

September 2013

Etanercept, Infliximab and Adalimumab are the best treatment options for improving the life quality ...

Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritis

Maxwell, James R.
Potter, Catherine
Hyrich, Kimme L.
Barton, Anne
Worthington, Jane
Isaacs, John D.
Morgan, Ann W.
Wilson, Anthony G.

November 2008

Anti-tumour necrosis factor (TNF) agents have revolutionized the treatment of patients with rheumato...

Genes Are Associated with the Response to TNF Inhibitors in Patients with Rheumatoid Arthritis

Conigliaro Paola
Ciccacci Cinzia
Politi Cristina
Triggianese Paola
Rufini Sara
Kroegler Barbara
Perricone Carlo
Latini Andrea
Novelli Giuseppe
Borgiani Paola
Perricone Roberto

January 2017

) in order to investigate their potential role in the response to therapy with tumor necrosis factor...

Pharmacogenomics of Anti-TNF Treatment Response Marks a New Era of Tailored Rheumatoid Arthritis Therapy

Tomasz Wysocki
Agnieszka Paradowska-Gorycka

February 2022

Rheumatoid arthritis (RA) is the most commonly occurring chronic inflammatory arthritis, the exact m...

Lack of Association of Variants Previously Associated with Anti-TNF Medication Response in Rheumatoid Arthritis Patients: Results from a Homogeneous Greek Population

Maria I. Zervou
Efsevia Myrthianou
Irene Flouri
Darren Plant
Gregory Chlouverakis
Panayiota Rapsomaniki
Anne Barton
Dimitrios T. Boumpas
George N. Goulielmos

August 2016

Treatment strategies blocking tumor necrosis factor (anti-TNF) have proven very successful in patien...

Published Online First

P P Tak
Slotervaart Hospital
Rheumatology F

January 2007

The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tum...

Ann Rheum Dis. Author manuscript

Miceli-richard Corinne
Comets Emmanuelle
Verstuyft C
Tamouza Ryad
Loiseau Pascale
Becquemont Laurent
Charron Dominique
Mariette Xavier

December 2014

A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthri...

Ann Rheum Dis. Author manuscript

Miceli-richard Corinne
Comets Emmanuelle
Verstuyft C
Tamouza Ryad
Loiseau Pascale
Becquemont Laurent
Charron Dominique
Mariette Xavier

September 2016

A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthri...

4

Verstuyft C
Tamouza R
Loiseau P
Ravaud P
Becquemont L
Charron D
Mariette X

June 2015

1 A single tumor necrosis factor α haplotype influences response to adalimumab in rheumatoid arthrit...

A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis.

Miceli-Richard, Corinne
Comets, Emmanuelle
Verstuyft, C.
Tamouza, Ryad
Loiseau, Pascale
Ravaud, Philippe
Kupper, H.
Becquemont, Laurent
Charron, Dominique
Mariette, Xavier

April 2008

International audienceOBJECTIVE: To determine whether tumour necrosis factor (TNF) gene polymorphism...

A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis.

Miceli-Richard, Corinne
Comets, Emmanuelle
Verstuyft, C.
Tamouza, Ryad
Loiseau, Pascale
Ravaud, Philippe
Kupper, H.
Becquemont, Laurent
Charron, Dominique
Mariette, Xavier

April 2008

International audienceOBJECTIVE: To determine whether tumour necrosis factor (TNF) gene polymorphism...

A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis.

Miceli-Richard, Corinne
Comets, Emmanuelle
Verstuyft, C.
Tamouza, Ryad
Loiseau, Pascale
Ravaud, Philippe
Kupper, H.
Becquemont, Laurent
Charron, Dominique
Mariette, Xavier

April 2008

International audienceOBJECTIVE: To determine whether tumour necrosis factor (TNF) gene polymorphism...

A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis.

Miceli-Richard, Corinne
Comets, Emmanuelle
Verstuyft, C.
Tamouza, Ryad
Loiseau, Pascale
Ravaud, Philippe
Kupper, H.
Becquemont, Laurent
Charron, Dominique
Mariette, Xavier

April 2008

International audienceOBJECTIVE: To determine whether tumour necrosis factor (TNF) gene polymorphism...

The tumour necrosis factor receptor superfamily member 1b 676T>G polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritis.

Toonen, E.J.M.
Coenen, M.J.H.
Kievit, W.
Fransen, J.
Eijsbouts, A.M.M.
Scheffer, H.
Radstake, T.R.D.J.
Creemers, M.C.W.
Rooij, D.J. de
Riel, P.L.C.M. van
Franke, B.
Barrera, P.

January 2008

OBJECTIVE: To assess the effect of a functional polymorphism (676T>G, M196R) in the tumour necrosis ...

The tumour necrosis factor receptor superfamily member 1b 676T>G polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritis.

Toonen, E.J.M.
Coenen, M.J.H.
Kievit, W.
Fransen, J.
Eijsbouts, A.M.M.
Scheffer, H.
Radstake, T.R.D.J.
Creemers, M.C.W.
Rooij, D.J. de
Riel, P.L.C.M. van
Franke, B.
Barrera, P.

January 2008

Item does not contain fulltextOBJECTIVE: To assess the effect of a functional polymorphism (676T>G, ...

The influence of TNFA genetic polymorphisms in the response to immunomodulatory drugs in patients with rheumatoid arthritis: a systematic review

Clemente, Daniela
Santos, Marlene

September 2013

Etanercept, Infliximab and Adalimumab are the best treatment options for improving the life quality ...

Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritis

Maxwell, James R.
Potter, Catherine
Hyrich, Kimme L.
Barton, Anne
Worthington, Jane
Isaacs, John D.
Morgan, Ann W.
Wilson, Anthony G.

November 2008

Anti-tumour necrosis factor (TNF) agents have revolutionized the treatment of patients with rheumato...

Genes Are Associated with the Response to TNF Inhibitors in Patients with Rheumatoid Arthritis

Conigliaro Paola
Ciccacci Cinzia
Politi Cristina
Triggianese Paola
Rufini Sara
Kroegler Barbara
Perricone Carlo
Latini Andrea
Novelli Giuseppe
Borgiani Paola
Perricone Roberto

January 2017

) in order to investigate their potential role in the response to therapy with tumor necrosis factor...

Pharmacogenomics of Anti-TNF Treatment Response Marks a New Era of Tailored Rheumatoid Arthritis Therapy

Tomasz Wysocki
Agnieszka Paradowska-Gorycka

February 2022

Rheumatoid arthritis (RA) is the most commonly occurring chronic inflammatory arthritis, the exact m...

Lack of Association of Variants Previously Associated with Anti-TNF Medication Response in Rheumatoid Arthritis Patients: Results from a Homogeneous Greek Population

Maria I. Zervou
Efsevia Myrthianou
Irene Flouri
Darren Plant
Gregory Chlouverakis
Panayiota Rapsomaniki
Anne Barton
Dimitrios T. Boumpas
George N. Goulielmos

August 2016

Treatment strategies blocking tumor necrosis factor (anti-TNF) have proven very successful in patien...

Published Online First

P P Tak
Slotervaart Hospital
Rheumatology F

January 2007

The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tum...

Published Online First

Abstract

Extracted data

Published Online First

Abstract

Extracted data

Related items

Related items